Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
User

Michael Burry

Scion Asset Management

Michael Burry Bristol-Myers Squibb Company stake

total: 173

Scion Asset Management BMY trades

Total transactions:
2
New positions:
1
Sold out:
1
Held since:
2021 Q4
Held for:
2 quarters
Latest activity:
2022 Q2
According to 2025 Q3 report, Michael Burry doesn't hold any Bristol-Myers Squibb Company (BMY) shares. To date, the estimated cost basis is nearly $62.35 for "buy" trades and estimated average "sell" price is $73.03. Scion Asset Management first purchased BMY in 2021 Q4, initially acquiring 300,000 shares. Since the initial investment in Bristol-Myers Squibb Company (BMY), Scion Asset Management has made 1 more transaction.

When did Michael Burry sell Bristol-Myers Squibb Company (BMY)?

Michael Burry sold off the entire Bristol-Myers Squibb Company (BMY) position in 2022 Q2.

When did Michael Burry buy Bristol-Myers Squibb Company (BMY)?

Michael Burry first invested in Bristol-Myers Squibb Company (BMY) in 2021 Q4 at the reported quarter-end price of $62.35 per share.

What's the cost basis of Scion Asset Management's BMY stake?

The estimated cost basis for Bristol-Myers Squibb Company (BMY) stake is around $62.35 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$62.35
Weighted AVG sell price:
$73.03

Michael Burry's historical trades in Bristol-Myers Squibb Company

2 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2022 Q2
0.00%
0
$73.03
-100% (-300,000)
-13.25%
2021 Q4
25.12%
300,000
$62.35
$18,705,000
new
+25.12%
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.